Actively Recruiting

Phase 1
Phase 2
Age: 18Years - 75Years
All Genders
NCT05459870

CAR-T Cells Targeting Autoimmune Diseases

Led by Shenzhen Geno-Immune Medical Institute · Updated on 2022-07-19

30

Participants Needed

2

Research Sites

204 weeks

Total Duration

On this page

Sponsors

S

Shenzhen Geno-Immune Medical Institute

Lead Sponsor

G

Guilin Hospital of Chinese Traditional and Western Medicine

Collaborating Sponsor

AI-Summary

What this Trial Is About

The purpose of this study is to assess the feasibility, safety and efficacy of CAR-T cell therapy in patients with autoimmune disease. Another goal of the study is to learn more about the safety and function of the CAR-T cells and their persistency in autoimmune disease patients.

CONDITIONS

Official Title

CAR-T Cells Targeting Autoimmune Diseases

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age older than 18 years
  • Expression of B cell surface molecules
  • Karnofsky Performance Score (KPS) over 80 points and survival time more than 3 months
  • Hemoglobin (Hgb) greater than 80 g/L
  • No contraindications to blood cell collection
Not Eligible

You will not qualify if you...

  • Presence of other active diseases making treatment response difficult to assess
  • Uncontrolled bacterial, fungal, or viral infection
  • Living with HIV
  • Active hepatitis B virus (HBV) or hepatitis C virus (HCV) infection
  • Pregnant or nursing mothers
  • Systemic steroid treatment within one week before treatment
  • Prior failed CAR-T cell treatment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Shenzhen Geno-immune Medical Institute

Shenzhen, Guangdong, China, 518000

Actively Recruiting

2

Guilin Hospital of Chinese Traditional and Western Medicine

Guilin, Guangxi, China, 541000

Actively Recruiting

Loading map...

Research Team

L

Lung-Ji Chang, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here